Author:
Lu Xiaoyan,Joshi Amita,Flomenberg Phyllis
Reference301 articles.
1. Abbink P, Lemckert A, Ewald B, Lynch D, Denholtz M, Smits S, et al. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol. 2007;81(9):4654–63.
2. Abzug MJ, Levin MJ. Neonatal adenovirus infection: four patients and review of the literature. Pediatrics. 1991;87(6):890–6.
3. Adenovirus type 4 and type 7 live oral vaccine prescribing information. n.d.. http://www.fda.gov/downloads/BiologicsBloodVaccines/ApprovedProducts/UCM247515.pdf
4. Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001;32(9):1325–30.
5. Allard A, Albinsson B, Wadell G. Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis. J Clin Microbiol. 2001;39(2):498–505.